Leanne Kelly, Chief Financial Officer at GRI Bio (NASDAQ:GRI), reported a large acquisition of company stock options on September 26, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Kelly, Chief Financial Officer at GRI Bio, a company in the Health Care sector, was just awarded stock options worth 83,333 shares of GRI. The options give Kelly the right to buy the company's stock at $1.52 per share.
GRI Bio shares are trading up 1.76% at $1.73 at the time of this writing on Wednesday morning. Since the current price is $1.73, this makes Kelly's 83,333 shares worth $144,166.